On Feb. 10, the company will hold a conference call to go over its latest results for the fourth quarter, which will be an ...

CVS Health is scheduled to release its fourth-quarter results next month, with analysts anticipating a double-digit decline ...

CVS Health (CVS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor ...

CVS Health CVS is scheduled to report third-quarter 2025 results on Oct. 29, before the market opens. The Zacks Consensus Estimate for third-quarter earnings per share (EPS) suggests a 24.8% increase ...

CVS Health Corporation is rated a Buy with an 18% upside to a $97 price target, citing robust business momentum and undervaluation. CVS posted a strong FQ2 2025 double-beat, with revenue up 8.4% and ...

In the last year, multiple insiders have substantially increased their holdings of CVS Health Corporation stock, indicating that insiders' optimism about the company's prospects h ...

CVS has emerged as an outlier during the ongoing implosion observed in the healthcare insurance sector, as they drive improved YoY margins despite the rising medical costs. This is on top of the ...

Investors interested in stocks from the Medical Services sector have probably already heard of CVS Health (CVS) and HealthEquity (HQY). But which of these two stocks presents investors with the better ...

Forbes contributors publish independent expert analyses and insights. Investment manager, former staffer at Forbes and Wall Street Journal. There are many ways companies can manipulate their reported ...